Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.00
(
0.52%
)
US TECH 100
26,545.60
(
0.31%
)
Dow Jones
49,525.81
(
1.36%
)
Brent Oil
109.20
(
-2.83%
)
Bitcoin
76,087.55
(
0.41%
)
News Focus
News Focus
Post# of 257471
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122912
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: semi_infinite post# 238305

Wednesday, 09/29/2021 9:31:00 AM

Wednesday, September 29, 2021 9:31:00 AM

Post# of 257471
FOLD spins off gene-therapy subsidiary, Caritas Therapeutics, which will go public via a reverse-merger with ARYD SPAC:

https://www.globenewswire.com/news-release/2021/09/29/2305173/15991/en/Amicus-Therapeutics-and-ARYA-Sciences-Acquisition-Corp-IV-Announce-Formation-of-a-Next-Generation-Genetic-Medicine-Company-Caritas-Therapeutics.html

Following the reverse-merger, FOLD will retain a 36% equity stake in Caritas.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today